Loring Wolcott & Coolidge Fiduciary Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,500
Closed -$7.8K 674
2023
Q1
$7.8K Hold
6,500
﹤0.01% 526
2022
Q4
$9.23K Hold
6,500
﹤0.01% 505
2022
Q3
$16K Hold
6,500
﹤0.01% 502
2022
Q2
$15K Hold
6,500
﹤0.01% 527
2022
Q1
$44K Hold
6,500
﹤0.01% 456
2021
Q4
$59K Hold
6,500
﹤0.01% 446
2021
Q3
$66K Hold
6,500
﹤0.01% 434
2021
Q2
$83K Buy
+6,500
New +$89.2K ﹤0.01% 422
2021
Q1
Sell
-6,500
Closed -$69K 746
2020
Q4
$69K Buy
+6,500
New +$59K ﹤0.01% 396
2017
Q4
Sell
-2
Closed 900
2017
Q3
$0 Buy
+2
New +$43 ﹤0.01% 926

Other funds holding DBD

Loring Wolcott & Coolidge Fiduciary Advisors's DBD Position: Q2 2023 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 6,500 shares — an estimated $7.8K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in DBD in Q3 2017 and held it in 10 quarters. The position peaked at $83K in Q2 2021. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 6,500 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $7.8K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Diebold Nixdorf Incorporated in Q3 2017 and held it in 10 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Diebold Nixdorf Incorporated position peaked at $83K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.